Ralph Scully, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Replication | 19 | 2024 | 1427 | 4.760 |
Why?
|
DNA Breaks, Double-Stranded | 26 | 2024 | 606 | 3.760 |
Why?
|
DNA Repair | 28 | 2024 | 2050 | 2.900 |
Why?
|
Rad51 Recombinase | 9 | 2024 | 191 | 2.360 |
Why?
|
BRCA1 Protein | 21 | 2024 | 1155 | 2.300 |
Why?
|
BRCA2 Protein | 9 | 2024 | 802 | 1.960 |
Why?
|
Gene Conversion | 7 | 2024 | 69 | 1.720 |
Why?
|
Recombination, Genetic | 16 | 2021 | 1525 | 1.610 |
Why?
|
Chromatids | 7 | 2017 | 62 | 1.600 |
Why?
|
DNA-Binding Proteins | 21 | 2024 | 9615 | 1.500 |
Why?
|
Genomic Instability | 12 | 2024 | 716 | 1.400 |
Why?
|
DNA Helicases | 4 | 2021 | 854 | 1.170 |
Why?
|
DNA-Directed DNA Polymerase | 4 | 2021 | 481 | 1.120 |
Why?
|
Histones | 10 | 2017 | 2601 | 1.100 |
Why?
|
Gene Duplication | 2 | 2024 | 315 | 1.010 |
Why?
|
Sister Chromatid Exchange | 4 | 2011 | 60 | 0.940 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2024 | 177 | 0.920 |
Why?
|
Tandem Repeat Sequences | 3 | 2024 | 183 | 0.910 |
Why?
|
Chromosomes | 3 | 2022 | 578 | 0.820 |
Why?
|
Escherichia coli Proteins | 3 | 2021 | 1058 | 0.810 |
Why?
|
Chromatin | 8 | 2022 | 2981 | 0.800 |
Why?
|
DNA Damage | 16 | 2021 | 2469 | 0.780 |
Why?
|
Fanconi Anemia | 1 | 2022 | 327 | 0.670 |
Why?
|
DNA Repair Enzymes | 3 | 2021 | 343 | 0.560 |
Why?
|
Attachment Sites, Microbiological | 1 | 2016 | 26 | 0.540 |
Why?
|
Genes, BRCA1 | 6 | 2018 | 755 | 0.510 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 4 | 2017 | 167 | 0.480 |
Why?
|
Radiation, Ionizing | 4 | 2017 | 252 | 0.460 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2017 | 724 | 0.430 |
Why?
|
Ovarian Neoplasms | 6 | 2017 | 4916 | 0.420 |
Why?
|
Multienzyme Complexes | 1 | 2016 | 664 | 0.410 |
Why?
|
Animals | 40 | 2024 | 169246 | 0.400 |
Why?
|
Tumor Suppressor Proteins | 3 | 2017 | 2810 | 0.380 |
Why?
|
Nuclear Proteins | 7 | 2024 | 5804 | 0.370 |
Why?
|
Embryonic Stem Cells | 4 | 2017 | 1250 | 0.360 |
Why?
|
DNA | 8 | 2024 | 7214 | 0.360 |
Why?
|
Carrier Proteins | 5 | 2024 | 4937 | 0.360 |
Why?
|
Escherichia coli | 2 | 2021 | 4214 | 0.350 |
Why?
|
Endodeoxyribonucleases | 3 | 2024 | 165 | 0.350 |
Why?
|
Mice | 25 | 2022 | 82029 | 0.340 |
Why?
|
Endonucleases | 2 | 2022 | 371 | 0.330 |
Why?
|
S Phase | 4 | 2017 | 424 | 0.330 |
Why?
|
Breast Neoplasms | 9 | 2016 | 21206 | 0.320 |
Why?
|
Epistasis, Genetic | 1 | 2011 | 353 | 0.320 |
Why?
|
Cell Line | 12 | 2021 | 15597 | 0.320 |
Why?
|
Cell Cycle | 2 | 2021 | 2932 | 0.310 |
Why?
|
Eukaryotic Cells | 1 | 2009 | 192 | 0.300 |
Why?
|
Lysine | 1 | 2012 | 1000 | 0.300 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2014 | 2892 | 0.290 |
Why?
|
Gammaherpesvirinae | 1 | 2007 | 27 | 0.290 |
Why?
|
Genes, Reporter | 4 | 2017 | 1524 | 0.280 |
Why?
|
Aneuploidy | 1 | 2010 | 573 | 0.280 |
Why?
|
Exodeoxyribonucleases | 2 | 2021 | 191 | 0.260 |
Why?
|
Sequence Deletion | 2 | 2022 | 1497 | 0.260 |
Why?
|
Cell Cycle Proteins | 6 | 2014 | 3445 | 0.240 |
Why?
|
Recombinant Fusion Proteins | 2 | 2011 | 3740 | 0.240 |
Why?
|
Genes, BRCA2 | 2 | 2004 | 593 | 0.220 |
Why?
|
Deoxyribonuclease I | 1 | 2024 | 228 | 0.220 |
Why?
|
Poly(ADP-ribose) Polymerases | 3 | 2014 | 428 | 0.220 |
Why?
|
Green Fluorescent Proteins | 4 | 2011 | 2065 | 0.220 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2010 | 957 | 0.210 |
Why?
|
Micrococcal Nuclease | 1 | 2022 | 36 | 0.210 |
Why?
|
Introns | 1 | 2005 | 966 | 0.200 |
Why?
|
Transfection | 3 | 2021 | 5755 | 0.190 |
Why?
|
Lamin Type B | 1 | 2021 | 28 | 0.190 |
Why?
|
Replication Protein A | 3 | 2017 | 54 | 0.190 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2005 | 663 | 0.190 |
Why?
|
Mutation | 13 | 2021 | 30238 | 0.180 |
Why?
|
Serine | 1 | 2004 | 831 | 0.180 |
Why?
|
Cells, Cultured | 7 | 2021 | 19015 | 0.180 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2021 | 148 | 0.180 |
Why?
|
Flow Cytometry | 3 | 2021 | 5902 | 0.170 |
Why?
|
Fibroblasts | 5 | 2021 | 4176 | 0.170 |
Why?
|
Crossing Over, Genetic | 2 | 2013 | 92 | 0.170 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2022 | 858 | 0.170 |
Why?
|
Virus Replication | 1 | 2007 | 2458 | 0.160 |
Why?
|
Oncogenes | 1 | 2024 | 1234 | 0.160 |
Why?
|
Ubiquitination | 2 | 2021 | 1009 | 0.150 |
Why?
|
Humans | 47 | 2024 | 768166 | 0.150 |
Why?
|
Blotting, Western | 4 | 2009 | 5027 | 0.150 |
Why?
|
Neoplasms | 2 | 2024 | 22371 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2017 | 43 | 0.140 |
Why?
|
Clone Cells | 1 | 2021 | 1670 | 0.140 |
Why?
|
Protein Binding | 7 | 2021 | 9343 | 0.140 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2017 | 98 | 0.140 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 153 | 0.140 |
Why?
|
Models, Biological | 5 | 2016 | 9495 | 0.130 |
Why?
|
Segmental Duplications, Genomic | 1 | 2016 | 20 | 0.130 |
Why?
|
Oncogene Proteins | 2 | 2018 | 717 | 0.130 |
Why?
|
Nucleosides | 1 | 2016 | 130 | 0.130 |
Why?
|
Erythroid Cells | 1 | 2017 | 237 | 0.120 |
Why?
|
Protein Subunits | 2 | 2015 | 943 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2010 | 2909 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2015 | 1901 | 0.120 |
Why?
|
Cell Line, Tumor | 10 | 2021 | 17140 | 0.120 |
Why?
|
Mutant Proteins | 1 | 2016 | 488 | 0.110 |
Why?
|
Cricetinae | 2 | 2009 | 2423 | 0.110 |
Why?
|
Nucleoside-Phosphate Kinase | 1 | 2013 | 24 | 0.110 |
Why?
|
Genome, Human | 2 | 2024 | 4446 | 0.110 |
Why?
|
HeLa Cells | 5 | 2021 | 3074 | 0.110 |
Why?
|
Phosphorylation | 5 | 2015 | 8317 | 0.100 |
Why?
|
Cricetulus | 2 | 2017 | 812 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18065 | 0.100 |
Why?
|
Genetic Complementation Test | 1 | 2013 | 557 | 0.100 |
Why?
|
Plasmids | 2 | 2009 | 2269 | 0.100 |
Why?
|
CHO Cells | 2 | 2017 | 1379 | 0.100 |
Why?
|
DNA, Bacterial | 1 | 2016 | 1478 | 0.090 |
Why?
|
Chromosome Breakage | 1 | 2011 | 159 | 0.090 |
Why?
|
Protein Transport | 2 | 2014 | 1951 | 0.090 |
Why?
|
Hydroxyurea | 1 | 2011 | 284 | 0.090 |
Why?
|
Methylation | 1 | 2012 | 1078 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 283 | 0.080 |
Why?
|
Transcription Factors | 2 | 2021 | 12168 | 0.080 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3428 | 0.080 |
Why?
|
Lasers | 1 | 2012 | 952 | 0.080 |
Why?
|
Exons | 1 | 2014 | 2394 | 0.070 |
Why?
|
Hydrolysis | 1 | 2009 | 646 | 0.070 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2012 | 701 | 0.070 |
Why?
|
DNA, Single-Stranded | 2 | 2021 | 351 | 0.070 |
Why?
|
Endometrial Neoplasms | 1 | 2016 | 1382 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 2 | 2014 | 1966 | 0.070 |
Why?
|
Models, Genetic | 2 | 2013 | 3447 | 0.070 |
Why?
|
Tamoxifen | 1 | 2011 | 966 | 0.070 |
Why?
|
Binding Sites | 2 | 2013 | 6020 | 0.070 |
Why?
|
Ultraviolet Rays | 1 | 2011 | 1103 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2457 | 0.060 |
Why?
|
Female | 17 | 2020 | 397192 | 0.060 |
Why?
|
Homozygote | 1 | 2010 | 1779 | 0.060 |
Why?
|
Herpesviridae Infections | 1 | 2007 | 269 | 0.060 |
Why?
|
Sirtuins | 1 | 2008 | 322 | 0.060 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9561 | 0.060 |
Why?
|
Saccharomyces cerevisiae Proteins | 3 | 2017 | 1839 | 0.060 |
Why?
|
Enzyme Activation | 1 | 2011 | 3590 | 0.060 |
Why?
|
Kinetics | 1 | 2012 | 6329 | 0.060 |
Why?
|
Open Reading Frames | 1 | 2007 | 818 | 0.060 |
Why?
|
Mammals | 1 | 2009 | 1135 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2017 | 14488 | 0.060 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2202 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 2004 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2253 | 0.050 |
Why?
|
Histone Chaperones | 2 | 2014 | 82 | 0.050 |
Why?
|
High Mobility Group Proteins | 1 | 2003 | 179 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2011 | 2451 | 0.050 |
Why?
|
Multiprotein Complexes | 2 | 2021 | 1110 | 0.050 |
Why?
|
Isoenzymes | 1 | 2006 | 1688 | 0.050 |
Why?
|
Mevalonic Acid | 1 | 2021 | 46 | 0.050 |
Why?
|
Alleles | 1 | 2013 | 6894 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 2633 | 0.040 |
Why?
|
Trans-Activators | 1 | 2010 | 2857 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2015 | 13421 | 0.040 |
Why?
|
Gene Amplification | 1 | 2005 | 1095 | 0.040 |
Why?
|
Viral Proteins | 1 | 2007 | 1802 | 0.040 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2020 | 97 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2003 | 671 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2015 | 2179 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2002 | 930 | 0.040 |
Why?
|
Cyclin E | 1 | 2018 | 155 | 0.040 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 17622 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2003 | 1105 | 0.040 |
Why?
|
Phthalazines | 1 | 2020 | 397 | 0.040 |
Why?
|
Genetic Diseases, Inborn | 1 | 2002 | 606 | 0.030 |
Why?
|
Gene Knockout Techniques | 2 | 2011 | 806 | 0.030 |
Why?
|
Chromosome Pairing | 1 | 2016 | 46 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2002 | 3055 | 0.030 |
Why?
|
Genes, p53 | 1 | 2018 | 714 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2016 | 125 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11878 | 0.030 |
Why?
|
Base Sequence | 2 | 2003 | 12421 | 0.030 |
Why?
|
DNA Ligases | 1 | 2015 | 81 | 0.030 |
Why?
|
Pedigree | 1 | 2003 | 4539 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5432 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 371 | 0.030 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2015 | 174 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1754 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2015 | 399 | 0.030 |
Why?
|
14-3-3 Proteins | 1 | 2015 | 221 | 0.030 |
Why?
|
Protein Conformation | 1 | 2021 | 3956 | 0.030 |
Why?
|
Thymine Nucleotides | 1 | 2013 | 57 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 183 | 0.030 |
Why?
|
Morpholines | 1 | 2016 | 584 | 0.030 |
Why?
|
Interphase | 1 | 2013 | 227 | 0.030 |
Why?
|
Protein Stability | 1 | 2014 | 580 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2014 | 438 | 0.030 |
Why?
|
Etoposide | 1 | 2014 | 639 | 0.030 |
Why?
|
Aminopyridines | 1 | 2016 | 580 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 451 | 0.020 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2012 | 111 | 0.020 |
Why?
|
Replication Protein C | 1 | 2011 | 26 | 0.020 |
Why?
|
Osteoblasts | 1 | 2017 | 1145 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1837 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 719 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 379 | 0.020 |
Why?
|
RecQ Helicases | 1 | 2011 | 53 | 0.020 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 11928 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2627 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7608 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1744 | 0.020 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 70 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 369 | 0.020 |
Why?
|
Cytoplasm | 1 | 2015 | 1505 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1505 | 0.020 |
Why?
|
Chromosomal Instability | 1 | 2011 | 176 | 0.020 |
Why?
|
Gamma Rays | 1 | 2011 | 319 | 0.020 |
Why?
|
Genetic Markers | 1 | 2016 | 2603 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 596 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8744 | 0.020 |
Why?
|
Stem Cells | 1 | 2002 | 3537 | 0.020 |
Why?
|
Time Factors | 1 | 2011 | 40218 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16726 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10474 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2008 | 220 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1606 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2013 | 13586 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1760 | 0.020 |
Why?
|
Cell Death | 1 | 2013 | 1679 | 0.020 |
Why?
|
Gene Targeting | 1 | 2011 | 841 | 0.020 |
Why?
|
Yeasts | 1 | 2008 | 279 | 0.020 |
Why?
|
Camptothecin | 1 | 2011 | 600 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 942 | 0.020 |
Why?
|
Genome | 1 | 2015 | 1754 | 0.020 |
Why?
|
Sirtuin 1 | 1 | 2008 | 247 | 0.020 |
Why?
|
Telomerase | 1 | 2012 | 751 | 0.020 |
Why?
|
Telomere | 1 | 2012 | 944 | 0.020 |
Why?
|
Thymus Neoplasms | 1 | 2008 | 274 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5403 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1767 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 2937 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 2832 | 0.010 |
Why?
|
Metabolomics | 1 | 2013 | 1674 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 2885 | 0.010 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13676 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2014 | 5151 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3728 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2003 | 327 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7598 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2830 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2011 | 4283 | 0.010 |
Why?
|
Protein Phosphatase 2 | 1 | 2003 | 231 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9523 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5703 | 0.010 |
Why?
|
Lymphoma | 1 | 2008 | 1898 | 0.010 |
Why?
|
DNA Primers | 1 | 2002 | 2828 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22379 | 0.010 |
Why?
|
Male | 3 | 2020 | 364719 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2003 | 1750 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2008 | 3139 | 0.010 |
Why?
|
Genomics | 1 | 2013 | 5926 | 0.010 |
Why?
|
Oligopeptides | 1 | 2002 | 1194 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2003 | 2885 | 0.010 |
Why?
|
Breast | 1 | 2003 | 1976 | 0.010 |
Why?
|
Antibodies | 1 | 2002 | 2421 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6082 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23645 | 0.010 |
Why?
|
Genetic Variation | 1 | 2002 | 6611 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 2003 | 10266 | 0.000 |
Why?
|
Brain | 1 | 2008 | 27360 | 0.000 |
Why?
|